BETR-D Study Shows 11% C. diff Reduction

Posted by Tru-D SmartUVC 04.26.17

The Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study is the first and only randomized clinical trial on UV disinfection.

The study’s primary outcome showed that enhanced terminal room disinfection strategies that utilized Tru-D reduced the risk of acquisition and infection by a cumulative 30 percent among patients who entered the same room of four major superbugs (C. diff, MRSA, VRE and Acinetobacter). However, a secondary analysis also showed a statistically significant, hospital-wide 11% reduction of C. diff when both bleach and UV were used.

Hospitals face challenges every day with infections. Tru-D adds a layer of protection in the disinfection process to help keep patients and staffs safe. Contact us at info@tru-d.com to see how we can help build a business case for cost avoidance with Tru-D at your hospital.  

Posted 04.26.17
  • Share

Never miss the latest in UV news.
Subscribe to UVC360 today.

Sign Up »